Keji Pharmaceuticals-B (02171) issued an announcementrpgcryptogameOn May 7, 2024, the Company granted 260,000 share options to three share option grantees in accordance with the terms of the post-IPO share option plan, subject to acceptance by the share option grantees. The exercise price of the options granted is 5.5 per sharerpgcryptogame.94 Hong Kong dollars.
On May 7, 2024, the Company granted 60,000 RSUs to a RSU grantee in accordance with the terms of the Post-IPO RSU Plan, subject to acceptance by the RSU grantee.